Skip to content
Start a diagnostic

WHO WE ARE

Clinical programmes
fail at the interfaces.

MB & Partners brings together medical, regulatory, payer and operational perspectives into one accountable decision system — so the right evidence is generated, the right decisions are made, and programmes advance with confidence.

Different perspectives.
A clearer path.

FROM CLIENT PROBLEM TO DECISION CONTROL

A clear path to your next consequential decision

We help clients turn complex questions into disciplined decisions, and then into controlled execution,
across medical, regulatory, payer and operational interfaces.
01

Define the
decision question

Clarify what must be decided, why it matters and what success looks like.

02

Integrate
perspectives

Bring medical, regulatory, payer and operational views into one analysis.

03

Design the
evidence strategy

Focus only on what the decision requires — no more, no less.

04

Execute with
discipline

Keep the plan on track across studies, vendors and geographies.

05

Reach the decision
and move forward

Leave with clear recommendations and a path to implementation.

ONE ACCOUNTABLE OPERATING MODEL

One strategy. One governance logic.

MB & Partners works through an integrated model that aligns strategy, evidence and execution under a single governance logic.

Compact Manolo Beelke & Partners brand mark.

& Partners

Strategic advisory

Senior advice across medical, regulatory, payer and operational strategy.

Verum Clinical Research logo.

Global Projectmanagment

The accountable project, analysis and evidence generation arm.

NECTAR global clinical trial execution network.

NECTAR

Clinical trial
execution

Selected Parter-CROs, qualified external CRCs, specialists and scientific advisors.

Connected expertise
for better decisions.

OUR BELIEF

Scientific integrity. Decision quality.
Execution control.

Independent judgment comes first. Every operating choice must preserve the ability to interpret the result, defend it to regulators and payers, and make the next capital-allocation decision.

Make uncertainty explicit before it becomes hidden cost.

Integrate medical, regulatory, payer, commercial and operational reasoning.

Prefer clear decision rights over open-ended diffusion.

Measure progress by decisions made, not activity volume.

Protect the credibility of the evidence through independent advice.

MEET THE FOUNDER

Manolo Beelke, MD, PhD

Physician-scientist. Clinical-development strategist.

Manolo has designed, led or advised more than 100 studies across Phase I–IV, with deep experience at the interfaces of medicine, regulation, market access and global execution.

Manolo Beelke in professional discussion, clinical development strategist and fractional CMO.

“Better decisions
for more patients.”

Manolo Beelke, MD, PhD
Founder, MB & Partners

A CONVERSATION CAN CHANGE THE TRAJECTORY

Turn your next critical decision into progress.

Start with a focused conversation about your programme, your key decision and how we can help.